Michiel T. Van Diepen

University Of Cape Town
Cape Town, WC 7925, South Africa

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Impact of modification of envelope proteins on the mechanical properties of HIV virus-like particles.

Impact of modification of envelope proteins on the mechanical properties of HIV virus-like particles.

Journal: Journal of the mechanical behavior of biomedical materials

Published: October 15, 2025

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Heterologous Immunization with Improved HIV-1 Subtype C Vaccines Elicit Autologous Tier 2 Neutralizing Antibodies with Rapid Viral Replication Control After SHIV Challenge.

Journal: Viruses

Published: December 05, 2024

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.

Needle-Free Devices and CpG-Adjuvanted DNA Improve Anti-HIV Antibody Responses of Both DNA and Modified Vaccinia Ankara-Vectored Candidate Vaccines.

Journal: Vaccines

Published: December 20, 2022

Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.

Development of a synthetic nanoparticle vaccine presenting the HIV-1 envelope glycoprotein.

Journal: Nanotechnology

Published: April 19, 2022

Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plants.

Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plants.

Journal: Biotechnology and bioengineering

Published: April 08, 2022

Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice.

Characterization of a Novel Chimeric Theileria parva p67 Antigen Which Incorporates into Virus-like Particles and Is Highly Immunogenic in Mice.

Journal: Vaccines

Published: December 16, 2021

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.

Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV.

Journal: Vaccines

Published: September 09, 2021

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.

Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector.

Journal: Vaccines

Published: September 08, 2021

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana.

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana.

Journal: Frontiers in plant science

Published: May 13, 2021

Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.

Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.

Journal: Vaccine

Published: July 22, 2020

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles.

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles.

Journal: Vaccines

Published: January 09, 2020

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens.

Characterization and Immunogenicity of HIV Envelope gp140 Zera® Tagged Antigens.

Journal: Frontiers in bioengineering and biotechnology

Published: November 15, 2019

Showing 1-12 of 23

Last Updated: 09/26/2026